Asp
|
asp
|
Analysis of point mutations in the USF1 and NF-kappaB sites in the cis-acting elements of ASP promoter region shows that USF1 and NF-kappaB are required for ASP activity |
PubMed
|
Envelope surface glycoprotein gp120
|
env
|
The binding of soluble HIV-1 gp120 to TLR2 or TLR4 results in upregulation of the TNF-alpha and IL-8 production through NF-kappaB activation |
PubMed
|
|
env
|
HIV-1 gp120 and methamphetamine synergistically induce release of IL-6 through the NF-kappaB pathway in astrocytes |
PubMed
|
|
env
|
HIV-1 gp120-mediated increases in IL-8 production in astrocytes are mediated through the NF-KapaB pathway |
PubMed
|
|
env
|
HIV-1 gp120 induces a time-dependent IL-6 upregulation by translocating NF-kappaB1 from cytoplasm to nucleus in human astrocyte cells |
PubMed
|
|
env
|
HIV-1 gp120-mediated downregulation of P-gp is attenuated by SN50 (a nuclear factor-KappaB [NF-KappaB] inhibitor), suggesting involvement of NF-KappaB signaling in P-gp regulation in primary cultures of human fetal astrocytes |
PubMed
|
|
env
|
HIV-1 gp120 activates NF-kappaB by inducing phosphorylation of IkappaBalpha in human astrocyte cells |
PubMed
|
|
env
|
HIV-1 gp120-mediated upregulation of CCL5 expression requires the NF-kappaB pathway in astrocytes |
PubMed
|
|
env
|
Inhibition of NRF2 by siRNA results in increased NOX2, NFkappaB (p65/p50), TNF-alpha, and MMP-9 proteins in astrocytes exposed to HIV-1 gp120 |
PubMed
|
|
env
|
Increased neurotoxicity mediated by cocaine and gp120 involves signaling pathways including c-jun N-terminal kinase (JNK), p38, extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinases (MAPK), and nuclear factor (NF)-kappaB |
PubMed
|
|
env
|
PC-PLC is an upstream regulator of HIV-1 gp120-mediated NF-kappaB activation in human monocyte-derived macrophages |
PubMed
|
|
env
|
NF-kappaB and JNK signaling are involved in gp120-induced multidrug resistance protein 1 (Mrp1) regulation during an HIV-1 associated inflammatory response |
PubMed
|
|
env
|
Treatment of human hepatic stellate cells with gp120 significantly increases secretion and gene expression of CCL2, metalloprotease-1 and interleukin-6. Gp120 also induces activation of Akt, NF-kappaB, and p38(MAPK) |
PubMed
|
|
env
|
HIV-1 gp120 induces NF-kappaB activation and increases p21(cip1/waf1) and p27(kip1) protein levels in human mesangial cells |
PubMed
|
|
env
|
The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120 |
PubMed
|
|
env
|
HIV-1 gp120/CD4 interaction-induced NF-kappaB activation stimulates the hyperphosphorylation of IkappaB-alpha by IkappaB kinases (IKKs) |
PubMed
|
|
env
|
HIV-1 envelope protein gp120 is able to induce COX-2 mRNA and protein in human neuroblastoma cell lines that express CXCR4 and CCR5 but not CD4; gp120 induces COX-2 promoter transcription through NF-kappaB and activating protein-1 (AP-1) sites |
PubMed
|
|
env
|
CD4-p56Lck interaction is required for HIV-1 gp120-induced nuclear translocation of NF-kappaB in HeLa cells |
PubMed
|
|
env
|
The protein tyrosine kinase p56lck plays an active role in transmitting an HIV-1 gp120-mediated signal that increases the oxidative state of cells and as a consequence amplifies TNF-mediated NF-kappa B DNA binding |
PubMed
|
|
env
|
In CD4-positive Jurkat cells, gp120 enhances TNF-induced NF-kappa B activation |
PubMed
|
|
env
|
Binding of heat-inactivated HIV-1 (iHIV-1) or HIV-1 gp120 to infected resting PBMCs is sufficient to activate NF-kappa B and AP-1, to induce cell surface expression of CD25, and to commit cells to produce virus |
PubMed
|
|
env
|
HIV-1 gp120 and anti-CD4 antibodies induce a specific, significant decrease in the binding activity of NF-AT, NF-kappa B and AP-1, which leads to an inhibition of IL-2 production and cell proliferation |
PubMed
|
Envelope transmembrane glycoprotein gp41
|
env
|
HIV-1 Env gp41 activates NK-kB (NFKB1) in human brain microvascular endothelial cells |
PubMed
|
|
env
|
The HIV-1 gp41 cytoplasmic domain-induced NFkappaB activation requires TAK1, RelA, and NEMO proteins |
PubMed
|
|
env
|
The cytoplasmic domain (residues 704-773) of HIV-1 gp41 induces NFkappaB activation. Deletion of a 12 amino-acid sequence (762CLFSYHRLRDLL) in gp41 leads to a dramatic loss of the NFkappaB activation and tyrosine 766 is particularly important |
PubMed
|
Nef
|
nef
|
HIV-1 Nef modulates NFKB1 activation |
PubMed
|
|
nef
|
The (PxxP) regions that interact with SH3 domain-containing cellular kinases as well as two acidic C-terminal residues (E154/E155) are critical for Nef-mediated enhancement of NF-kappaB activity |
PubMed
|
|
nef
|
HIV-1 and SIVcpz Nef proteins enhance TNF-alpha, IKK-beta, and RelA/p65-induced NF-kappaB activation in 293T cells |
PubMed
|
|
nef
|
HIV-1 Nef activates nuclear transcription factor NF-kappaB in human monocyte/macrophages, promonoctyes, and dendritic cells, and to a lesser extent in immature dendritic cells |
PubMed
|
|
nef
|
Knockdown of the p50 and p65 subunits of NF-kappaB by siRNA shows significant reduction of CCL5 levels, suggesting that NF-kappaB is involved in Nef-mediated upregulation of CCL5 |
PubMed
|
|
nef
|
Stimulation of T cells by mitogens or antibodies to the T-cell receptor (TCR)-CD3 complex results in the downregulation of transcriptional factors NF-kappa B and AP-1 in cells expressing HIV-1 Nef |
PubMed
|
|
nef
|
The interaction of HIV-1 Nef with TRAF2, TRAF5, and TRAF6 proteins activates NF-kappaB, leading to the degradation of IkappaB-alpha and the increased phosphorylation of IKK-alpha and IKK-beta in monocyte-derived macrophages |
PubMed
|
|
nef
|
HIV-1 Nef upregulates TLR2 expression via NF-kappaB activation in THP-1 cells |
PubMed
|
|
nef
|
Both the myristoylation site and the acidic cluster in HIV-1 Nef are required for the activation of NF-kappaB, which induces upregulation of TNFalpha and IL6 expression |
PubMed
|
|
nef
|
HIV-1 Nef immunocomplexes analyzed by mass spectrometry reveal that NFKB-p105 is a Nef-binding protein in Jurkat cells |
PubMed
|
|
nef
|
Nef-mediated activation of NF-kappaB in macrophages induces secretion of the acute-phase protein ferritin, which is necessary and sufficient for Nef-dependent B cell changes |
PubMed
|
|
nef
|
HIV-1 Nef suppresses immunoglobulin class-switch DNA recombination by inducing IkappaBalpha and SOCS proteins, which block CD154, IL-4 and IL-10 cytokine signaling via NF-kappaB and STAT transcription factors |
PubMed
|
|
nef
|
HIV-1 Nef inhibits the induction of HIV-1- and interleukin 2-directed gene expression, and the effect on HIV-1 transcription depends on an intact NF-kappa B-binding site |
PubMed
|
|
nef
|
HIV-1 Nef expression in Drosophila inhibits NF-kappa-B activation |
PubMed
|
|
nef
|
HIV-1 Nef inhibits the induction of NF-kappa B DNA-binding activity by T-cell mitogens, however Nef does not affect the DNA-binding activity of other transcription factors implicated in HIV-1 regulation, including SP-1, USF, URS, and NF-AT |
PubMed
|
Tat
|
tat
|
HIV-1 Tat decreases NFKB1 (NF-kB) activation in Leishmania-infected macrophages |
PubMed
|
|
tat
|
HIV-1 Tat activates NFkappaB, causing the induction of CD95 ligand, CD69, iNOS, MCP-1, IL-2, IL-6, IL-8, IL-10, TNF-alpha, VCAM-1, ICAM-1, E-selectin, and MMP-9, as well as monocyte adhesion, cellular activation and angiogenesis |
PubMed
|
|
tat
|
Human microglia cells treated with HIV-1 clade C Tat show more significant upregulation of IL-6 and TNF-alpha, and higher NF-kappaB activation as compared to clade B Tat-treated cells |
PubMed
|
|
tat
|
HIV-1 Tat upregulates the expression of platelet-derived growth factor subunit B homodimer through activation of the PDGFR-B/MEK/NF-kappaB pathway in human brain microvascular pericytes |
PubMed
|
|
tat
|
HIV-1 Tat-mediated transcriptional activation of the HIV-1 LTR promoter requires NFkappaB binding sites in the promoter and involves the activation of NFkappaB by Tat |
PubMed
|
|
tat
|
HIV-1 Tat-mediated upregulation of CCL5 involves JAK2/3, AKT2/3, p38delta, NF-kappaB (p65/p50), C/EBP alpha/gamma, and AP-1 proteins |
PubMed
|
|
tat
|
HIV-1 Tat enhances the NFkappaB activity by inhibiting IkappaB-alpha binding to p65 RelA |
PubMed
|
|
tat
|
Exogenous Nef and TNF-alpha synergistically activate NF-kappaB and AP-1 resulting in enhancing HIV-1 Tat transactivation of the LTR and viral replication in both chronically infected promonocytic cells and acutely infected primary macrophages |
PubMed
|
|
tat
|
HIV-1 Tat recruits P/CAF to the integrated HIV-1 LTR promoter causing the acetylation of histones, which in turn leads to the recruitment the p65 subunit of NFkappaB to the promoter |
PubMed
|
|
tat
|
HIV-1 Tat induces the acetylation of the NFkappaB p50 subunit as well as the p50/p65 complex by p300, causing an increase in NFkappaB DNA binding activity and in the rate of transcription |
PubMed
|
|
tat
|
Extracellular HIV-1 Tat upregulates the expression of human beta-defensin 2 (hBD-2) via JNK/NF-KappaB/AP-1-dependent pathways in human B cells |
PubMed
|
|
tat
|
The transcription factors NF-KappaB and NF-AT contribute to the Tat-induced activation of the HERV-K (HML-2) gag RNA transcripts in Jurkat T cells and in primary lymphocytes |
PubMed
|
|
tat
|
HIV-1 Tat enhances the NFkappaB activity and promotes the transcriptional activation of MIP-1alpha by interacting with IkappaB-alpha and p65 RelA |
PubMed
|
|
tat
|
MiR-217 regulates HIV-1 Tat-induced activation of NF-kappaB and inactivation of AMPK in MAGI cells |
PubMed
|
|
tat
|
Inhibition of human telomerase reverse transcriptase (hTERT) results in the upregulation of HIV-1 Tat-induced overexpression of intercellular adhesion molecule-1 (ICAM1) via the nuclear factor-kappaB-regulated mechanism |
PubMed
|
|
tat
|
Acetylation-deficient cyclin T1 mutant dominantly suppresses NF-kappaB-mediated activation of the interleukin-8 promoter but continues to synergize with the HIV Tat protein to transactivate the HIV long terminal repeat |
PubMed
|
|
tat
|
Herpes virus saimiri-StpC synergizes with Tat during transcriptional activation of the HIV-1 LTR. This transcriptional synergy between StpC and Tat requires Lck and NF-kappaB consensus binding sequences |
PubMed
|
|
tat
|
Specific C/EBP and NF-kappaB transcription factor binding elements within the IL-1beta promoter are involved in Tat regulation of IL-1beta production |
PubMed
|
|
tat
|
Treatment of astrocytes with cell-permeable superoxide dismutase (SOD) leads to a decrease in Tat-induced ROS generation and NF-kappaB activation |
PubMed
|
|
tat
|
Glutamic acids at positions 92, 94, and 96 or lysine's at positions 88, 89, and 90 in the second encoding Tat exon are critical for the activation of NF-kappaB |
PubMed
|
|
tat
|
HIV-1 Tat binds the deacetylase domain (amino acids 341-512) of SIRT1 and inhibits SIRT1 deacetylase activity, which results in the induction of NF-kappaB hyperacetylation |
PubMed
|
|
tat
|
HIV-1 Tat-mediated upregulation of MMP-9 in human astrocytes results from NF-kappaB activation pathway |
PubMed
|
|
tat
|
PPARalpha and PPARgamma over-expression prevent Tat-induced binding activity and transactivation of nuclear factor-kappaB |
PubMed
|
|
tat
|
NFKB1 is downregulated in HIV-1 Tat and NC cotransfection of HEK 293T cells |
PubMed
|
|
tat
|
HIV-1 Tat in combination with IFN-gamma and TNF-alpha increases CXCL10 mRNA and protein in human astrocytes through the activation of the p38, Jnk, and Akt signaling pathways and their downstream transcription factors, NF-kappaB and STAT-1alpha |
PubMed
|
|
tat
|
NFAT-1 negatively regulates HIV-1 Tat-mediated transactivation of the HIV-1 LTR by competing with NFkappaB for its binding to the LTR, thereby blocking the interaction of NFkappaB with Tat |
PubMed
|
|
tat
|
HIV-1 Tat activates NFkappaB through the cellular interferon-inducible, double-stranded RNA dependent protein kinase, PKR |
PubMed
|
|
tat
|
Activation of NFkappaB by HIV-1 Tat leads to a reduction in adenylyl cyclase activity and an inhibition of cAMP synthesis |
PubMed
|
|
tat
|
Activation of NFkappaB by HIV-1 Tat is inhibited by Nitric Oxide |
PubMed
|
|
tat
|
HIV-1 Tat-induced SOCS3 expression inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages in a NF-kappaB-dependent manner |
PubMed
|
|
tat
|
Recombinant CD40L synergizes with HIV-1 Tat to increase TNF-alpha release from primary human monocytes and microglia in an NF-kappaB-dependent manner. This synergism is attributed to a Tat-mediated up-regulation of CD40 |
PubMed
|
|
tat
|
In HIV-1 Tat-expressing and HIV-infected astrocytes, endothelin-1 (ET-1) is significantly elevated through NF-kappaB (NF-kappaB)-responsive sites in the ET-1 promoter |
PubMed
|
|
tat
|
NFkappaB tethers the p160 nuclear receptor co-activator GRIP1 to the HIV-1 LTR promoter, thereby regulating the full activation of this promoter by HIV-1 Tat |
PubMed
|
|
tat
|
HIV-1 Tat has been shown to bind NFkappaB in vitro in gel shift, GST-pull down and affinity matrix assays |
PubMed
|
|
tat
|
p56-lck plays a critical role in the activation of NFkappaB by HIV-1 Tat |
PubMed
|
|
tat
|
HIV-1 Tat enhances tumor necrosis factor-induced activation of NFkappaB by downregulating manganese-dependent superoxide dismutase (MnSOD) |
PubMed
|
Vpr
|
vpr
|
HIV-1 Vpr activates NFKB1 dependent upon amino acids A30, A59, H71, R73, S79, and R80 in Vpr in HeLa cells transfected with an NF-kB luciferase reporter plasmid |
PubMed
|
|
vpr
|
HIV-1 Vpr activates NFKB1 in HeLa cells transfected with an NF-kB luciferase reporter plasmid, which leads to G2 cell cycle arrest |
PubMed
|
|
vpr
|
Upregulation of IL-6, IL-10, TNFalpha, and gamma interferon is linked to HIV-1 Vpr activation of NF-kappa B |
PubMed
|
|
vpr
|
TNF secreted by HIV-1-infected cells (which may be attributed to Vpr) enhances NFKB1 (NK-kappa-B) activity in bystander cells AND induces replication of HIV-1 (reactivation) in a model of latently infected cells (J-Lat 10.6 cells) |
PubMed
|
|
vpr
|
HIV-1 Vpr induced upregulation CXCL8 (IL8) involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes |
PubMed
|
|
vpr
|
HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes |
PubMed
|
|
vpr
|
HIV-1 Vpr-mediated upregulation of CXCL8 (IL8) involves NFKB1 (NF-kappa-B) |
PubMed
|
|
vpr
|
HIV-1 Vpr-mediated upregulation of IL6 involves NFKB1 (NF-kappa-B) |
PubMed
|
|
vpr
|
HIV-1 and SIVcpz Vpr proteins inhibit NF-kappaB, but the opposite is observed for SIVgsn/mus/mon Vpr proteins |
PubMed
|
|
vpr
|
HIV-1 Vpr regulates NF-kappa B, activating it in certain circumstances while suppressing it in others |
PubMed
|
|
vpr
|
The ability of HIV-1 Vpr to activate NF-kappaB or activator protein 1-dependent luciferase expression requires TAK1, TRAF6, or TAB3 in cells |
PubMed
|
|
vpr
|
HIV-1 Vpr-induced upregulation of CCL5 requires p50 and p65 subunits of NF-kappaB, p38delta MAPK, Akt-2 and Akt-3, and AP-1 transcription factor in HIV-1 Vpr transfected astrocytes |
PubMed
|
|
vpr
|
HIV-1 Vpr interacts with RelB to promote the Vpr-mediated activation of NF-kappaB reporter gene and to enhance the transactivation of HIV LTR |
PubMed
|
|
vpr
|
HIV-1 Vpr inhibits the NFkappaB signaling pathway in TNF-alpha treated cells and abolishes the phosphorylation of NFkappaB p65 subunit in response to such treatment |
PubMed
|
|
vpr
|
HIV-1 Vpr-induced IL-6 production depends on the activation of NFkappaB and the involvement of C/EBP-beta, TLR4, and MyD88 |
PubMed
|
|
vpr
|
Recruitment of PARP-1 by HIV-1 Vpr-glucocorticoid receptor (GR) complex prevents its nuclear localization, which is necessary for Vpr to suppress NF-kappaB |
PubMed
|
|
vpr
|
HIV-1 Vpr activation of NF-kappa B regulated promoters is linked to Vpr regulation of IL-12, CD44, Toll-like receptor 4, indolamine 2,3-dioxygenase, macrophage receptor with collagenous structure, and thrombospondin 1 |
PubMed
|
|
vpr
|
HIV-1 Vpr potentiates the trans-activation, but not the trans-repression, properties of the glucocorticoid receptor on NF-kappa B-regulated simple promoters |
PubMed
|
|
vpr
|
HIV-1 Vpr increases IL-8 expression and IL-8 promoter activity by activating transcription factors NF-kappa B and NF-IL-6 and also increases transcription of NF-kappa B and NF-IL-6 enhancer containing viral promoters |
PubMed
|
|
vpr
|
NF-kappa B contributes to HIV-1 transactivation by HIV-1 Vpr but is not completely responsible for this effect |
PubMed
|
|
vpr
|
Data suggests that p300, through its interactions with NF-kappa B, basal transcriptional components, and Cdks, is modulated by HIV-1 Vpr and regulates HIV replication |
PubMed
|
|
vpr
|
Vpr suppresses expression of IL-2, IL-10, IL-12, TNFalpha and IL-4, all of which are NF-kappa B-dependent |
PubMed
|
|
vpr
|
Regulation of apoptosis by HIV-1 Vpr is linked to Vpr suppression of NF-kappa B activity via the induction of I kappa B and is mapped to the first alpha-helical domain (amino acids 17-34) of Vpr |
PubMed
|
Vpu
|
vpu
|
HIV-1 Vpu modulates NFKB1 activation |
PubMed
|
|
vpu
|
HIV-1 Vpu inhibits NF-kappa B activation by interfering with beta-TrCP-mediated degradation of IkappaB-alpha |
PubMed
|
|
vpu
|
Most HIV-1 and primate lentiviral Vpu proteins inhibit IKK-beta-induced NF-kappaB activation except HIV-1 group N Vpu proteins |
PubMed
|
|
vpu
|
HIV-1 Vpu inhibits endogenous expression BST2-induced NF-kappaB activity in cells, and the inhibition requires the beta-TrCP binding motif (residues 51-56; DSGxxS) in Vpu |
PubMed
|
|
vpu
|
NF-kappaB-mediated enhancement of the IFN-beta promoter activity is inhibited by HIV-1 Vpu |
PubMed
|
|
vpu
|
HIV-1 Vpu interferes with beta-TrCP to inhibit TNF-alpha-induced activation of NFkappaB |
PubMed
|
capsid
|
gag
|
HIV-1 CA mutants N74D and P90A fail to bind to CPSF6 and cyclophilins (Nup358 and CypA), respectively, and trigger innate sensors, leading to nuclear translocation of NFkappaB and IRF3, production of type 1 IFN and induction of an antiviral state |
PubMed
|
nucleocapsid
|
gag
|
NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) is downregulated in HIV-1 Tat and NC cotransfection of HEK 293T cells |
PubMed
|
|
gag
|
HIV-1 Nucleocapsid has been shown to bind to the HIV-1 LTR promoter and enhance NF-kappaB, Sp1, and TFIIB-induced HIV-1 LTR-directed RNA transcription |
PubMed
|
retropepsin
|
gag-pol
|
HIV-1 protease can cleave p105 into a p45 maturation product and increases levels of active nuclear NF-kappa B complex |
PubMed
|